• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴茎勃起功能障碍目标导向治疗的结果分析

Outcome analysis of goal directed therapy for impotence.

作者信息

Jarow J P, Nana-Sinkam P, Sabbagh M, Eskew A

机构信息

Department of Urology, Bowman Gray School of Medicine, Winston-Salem, North Carolina, USA.

出版信息

J Urol. 1996 May;155(5):1609-12.

PMID:8627834
Abstract

PURPOSE

We assessed patient preference, satisfaction and overall outcome of goal directed management of erectile dysfunction.

MATERIALS AND METHODS

The results of goal directed therapy of impotence were assessed by an independent telephone survey of 377 consecutive men who had not received prior therapy and who were followed for a minimum of 2 years.

RESULTS

Patients preferred medical to surgical therapies despite significantly higher satisfaction rates achieved with surgery. Average number of treatment modalities chosen by each patient was 2 (range 0 to 5). Ultimately, only 40% of the patients achieved a long-term satisfactory result with goal directed therapy. The remainder were not satisfied with the last treatment but chose no further therapy, were lost to followup or refused therapy from the outset.

CONCLUSIONS

Our results clearly demonstrate a patient preference for the least invasive forms of therapy. Patients avoid significantly more effective but also more invasive treatment options despite unsatisfactory results with less invasive methods. Future research efforts should be concentrated on the development of new medical therapies to enhance overall patient satisfaction.

摘要

目的

我们评估了勃起功能障碍目标导向管理的患者偏好、满意度及总体结果。

材料与方法

通过对377名未接受过先前治疗且随访至少2年的连续男性进行独立电话调查,评估阳痿目标导向治疗的结果。

结果

尽管手术治疗的满意度明显更高,但患者更喜欢药物治疗而非手术治疗。每位患者选择的治疗方式平均为2种(范围为0至5种)。最终,只有40%的患者通过目标导向治疗获得了长期满意的结果。其余患者对最后一次治疗不满意,但未选择进一步治疗,失访或从一开始就拒绝治疗。

结论

我们的结果清楚地表明患者偏好侵入性最小的治疗方式。尽管侵入性较小的方法效果不理想,但患者仍避免选择明显更有效但侵入性也更强的治疗方案。未来的研究应集中在开发新的药物治疗方法以提高患者的总体满意度。

相似文献

1
Outcome analysis of goal directed therapy for impotence.阴茎勃起功能障碍目标导向治疗的结果分析
J Urol. 1996 May;155(5):1609-12.
2
Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy.阴茎假体与海绵体内注射疗法的长期疗效比较。
J Urol. 1998 Mar;159(3):811-5.
3
Patient satisfaction with current impotence therapy.患者对当前阳痿治疗的满意度。
Wis Med J. 1995 Oct;94(10):542-4.
4
Comparative results of goal oriented therapy for erectile dysfunction.勃起功能障碍目标导向治疗的比较结果
J Urol. 1997 Jun;157(6):2135-8.
5
Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.首次接受磷酸二酯酶5抑制剂治疗的男性中,与选择西地那非和他达拉非治疗勃起功能障碍相关的因素:一项多中心、随机、开放标签、交叉研究数据的事后分析
BJU Int. 2007 Jul;100(1):122-9. doi: 10.1111/j.1464-410X.2007.06916.x.
6
Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction.枸橼酸西地那非治疗勃起功能障碍的疗效、安全性及患者接受度。
J Urol. 2000 Oct;164(4):1192-6.
7
Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.西地那非、海绵体内注射前列腺素E1及阴茎植入手术治疗泌尿外科勃起功能障碍患者的满意度及勃起功能比较
J Urol. 2003 Jul;170(1):159-63. doi: 10.1097/01.ju.0000072524.82345.6d.
8
The use of treatments for erectile dysfunction among survivors of prostate carcinoma.前列腺癌幸存者中勃起功能障碍治疗方法的使用情况。
Cancer. 2002 Dec 1;95(11):2397-407. doi: 10.1002/cncr.10970.
9
Concomitant use of sildenafil and a vacuum entrapment device for the treatment of erectile dysfunction.西地那非与真空吸引装置联合用于治疗勃起功能障碍。
J Urol. 2004 Jan;171(1):292-5. doi: 10.1097/01.ju.0000098460.02560.fe.
10
Primary penile venous leakage surgery with crural ligation in men with erectile dysfunction.针对勃起功能障碍男性进行的阴茎主要静脉漏手术及海绵体脚结扎术。
J Urol. 2008 Sep;180(3):1056-9. doi: 10.1016/j.juro.2008.05.024. Epub 2008 Jul 17.

引用本文的文献

1
The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy.前列腺癌康复诊所:一家针对根治性前列腺切除术后性功能障碍的生物心理社会诊所。
Curr Oncol. 2018 Dec;25(6):393-402. doi: 10.3747/co.25.4111. Epub 2018 Dec 1.
2
Non-pharmacological and non-surgical strategies to promote sexual recovery for men with erectile dysfunction.促进勃起功能障碍男性性功能恢复的非药物和非手术策略。
Transl Androl Urol. 2017 Nov;6(Suppl 5):S776-S794. doi: 10.21037/tau.2017.04.09.
3
Trazodone in methandone induced erectile dysfunction.
曲唑酮治疗美沙酮所致勃起功能障碍
Iran J Psychiatry. 2010 Fall;5(4):164-6.
4
The effect of sildenafil citrate and pentoxifylline combined treatment in the management of erectile dysfunction.枸橼酸西地那非与己酮可可碱联合治疗对勃起功能障碍的疗效
Int Urol Nephrol. 2008;40(1):133-6. doi: 10.1007/s11255-007-9255-1. Epub 2007 Sep 1.
5
Nonpharmacologic treatment of erectile dysfunction.勃起功能障碍的非药物治疗
Rev Urol. 2002;4 Suppl 3(Suppl 3):S9-S16.
6
Advances in the Management of Post-Radical Prostatectomy Erectile Dysfunction: Treatment Strategies When PDE-5 Inhibitors Don't Work.根治性前列腺切除术后勃起功能障碍的管理进展:磷酸二酯酶5抑制剂无效时的治疗策略
Rev Urol. 2005;7 Suppl 2(Suppl 2):S39-50.
7
Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.他达拉非对埃及和土耳其勃起功能障碍男性的疗效。
Int J Clin Pract. 2006 Jul;60(7):812-9. doi: 10.1111/j.1742-1241.2006.00993.x.
8
The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions.英国国家医疗服务体系管理勃起功能障碍的成本:西地那非及处方限制的影响。
Pharmacoeconomics. 2002;20(13):879-89. doi: 10.2165/00019053-200220130-00002.
9
Management of erectile dysfunction following radical prostatectomy.根治性前列腺切除术后勃起功能障碍的管理
Curr Urol Rep. 2001 Dec;2(6):495-503. doi: 10.1007/s11934-001-0045-5.
10
Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.使用决策分析模型评估男性勃起功能障碍的经济成本:以一个拥有10万名成员的假设性管理式医疗计划为例。
Pharmacoeconomics. 2000 Jan;17(1):77-107. doi: 10.2165/00019053-200017010-00006.